|
|
Correlation between the level of thrombomodulin during pregnancy and postpartum vascular endothelial function in patients with preeclampsia |
YANG Yawen1 ZHOU Qiaojuan2 ZHAO Ai1 SHAO Wen1▲ |
1.Department of Obstetrics, Huai’an First People’s Hospital, Jiangsu Province, Huai’an 223300, China;
2.Department of Ultrasonography, Huai’an First People’s Hospital, Jiangsu Province, Huai’an 223300, China
|
|
|
Abstract Objective To study the correlation between the level of thrombomodulin (TM) during pregnancy and postpartum vascular endothelial function in patients with preeclampsia (PE). Methods A total of 108 PE patients in Huai’an First People’s Hospital, Jiangsu Province from February 2018 to February 2021 were selected. All patients were tested for TM levels during pregnancy, according to endothelial dependent flow mediated dilation value at six weeks postpartum, they were divided into abnormal vascular endothelial function group and normal vascular endothelial function group. The influencing factors of postpartum vascular endothelial dysfunction were analyzed, and the predictive value of TM on vascular endothelial function was evaluated by receiver operating characteristic curve. Results Systolic blood pressure (SBP), diastolic blood pressure (DBP), homocysteine (Hcy), hypersensitive C-reactive protein (hs-CRP), and TM in abnormal vascular endothelial function group were higher than those in normal vascular endothelial function group (P<0.05). TM level during pregnancy was negatively correlated with vascular endothelial function in PE patients (r=-0.416, P<0.05). SBP, DBP, hs-CRP, and TM were the influencing factors of vascular endothelial function (OR=3.592, 2.641, 4.675, 3.872,P<0.05). The cut-off value of TM during pregnancy for predicting postpartum vascular endothelial dysfunction was 44.87 μg/L, area under the curve was 0.865, sensitivity was 85.11%, and specificity was 83.61%. Conclusion The TM level of PE patients during pregnancy is closely related to postpartum vascular endothelial function, which can provide reasonable basis for clinical diagnosis and treatment.
|
|
|
|
|
[1] 徐振华,马廷学,王永红.中性粒细胞活化导致血管内皮功能损伤在子痫前期发病中的作用研究进展[J].国际妇产科学杂志,2020,47(4):365-368.
[2] Turbeville HR,Sasser JM. Preeclampsia beyond pregnancy:long-term consequences for mother and child [J]. Am J Physiol Renal Physiol,2020,318(6):F1315-F1326.
[3] 李园园,田晓予,杨雪,等.子痫前期预测指标及症状前治疗的研究进展[J].中国计划生育学杂志,2020,28(5):782-786.
[4] 魏俊,刘国莉.重视子痫前期预防发病中抗凝药物的应用[J].中国妇产科临床杂志,2020,21(3):225-226.
[5] 牛小芸,谢喜秀.血栓调节蛋白在疾病中的作用[J].中国生物化学与分子生物学报,2021,37(8):998-1004.
[6] 李丽,罗晓梅,张媛媛,等.血清血栓调节蛋白、类血管生成素6和β-痕迹蛋白对妊娠期高血压疾病的诊断价值[J].现代医学,2020,48(10):1276-1279.
[7] 中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南(2020)[J].中华妇产科杂志,2020, 54(4):227-238.
[8] Corretti MC,Anderson TJ,Benjamin EJ,et al. Guidelines for the ultrasound assessment of endothelial-dependent flow- mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force [J]. J Am Coll Cardiol,2002,39(2):257-265.
[9] Rana S,Lemoine E,Granger JP,et al. Preeclampsia:Pathophysiology,Challenges,and Perspectives [J]. Circ Res,2019, 124(7):1094-1112.
[10] 李娜娜.妊娠期高血压和子痫前期对孕妇产后血管内皮功能的影响[J].航空航天医学杂志,2021,32(8):925- 927.
[11] Dikalova AE,Pandey A,Xiao L,et al. Mitochondrial Deacetylase Sirt3 Reduces Vascular Dysfunction and Hypertension While Sirt3 Depletion in Essential Hypertension Is Linked to Vascular Inflammation and Oxidative Stress [J]. Circ Res,2020,126(4):439-452.
[12] 胡凤丽.子痫前期孕妇动脉弹性与氧化应激损伤、血管内皮功能的相关性[J].中国计划生育学杂志,2021,29(6):1282-1285.
[13] 季燕雯,陈先侠,王海霞,等.早发型子痫前期内皮细胞损伤机制的研究进展[J].临床误诊误治,2020,33(4):111-115.
[14] 白延涛,李燕,石全宝.沙库巴曲缬沙坦对缺血性心肌病病人血流介导血管扩张功能及颈动脉内膜中层厚度的影响[J].中西医结合心脑血管病杂志,2020,18(17):2879-2881.
[15] 马孝湘,王林,杨雁华,等.肱动脉血流介导的舒张功能在体检人群心血管病风险评估中的应用价值[J].四川医学,2020,41(12):1223-1227.
[16] 叶玲,吕永烨,刘蓉.尿激酶对深静脉血栓大鼠体内炎症物质和血栓调节蛋白的影响[J].中国医师杂志,2022, 24(2):270-274.
[17] 李传保,徐冷楠,步霄霄,等.可溶性血栓调节蛋白对评估肾脏病患者内皮损伤状态的价值[J].中华医学杂志,2021,101(23):1812-1815.
[18] 姜洁,吕菁君,叶璐,等.可溶性血栓调节蛋白及中性粒细胞明胶酶相关脂质运载蛋白早期预测脓毒症相关急性肾损伤的临床研究[J].中华急诊医学杂志,2020,29(4):533-540.
[19] Giri H,Cai X,Panicker SR,et al. Thrombomodulin Regulation of Mitogen-Activated Protein Kinases [J]. Int J Mol Sci,2019,20(8):1851.
[20] 郭俊,许强宏.脓毒症患者血栓调节蛋白和纤溶酶原激活物抑制剂-1及内皮细胞损伤程度的研究初探[J].中华内科杂志,2021,60(2):143-146.
[21] 钟林翠,宋景春,邓星平,等.血栓调节蛋白联合凝血酶-抗凝血酶复合物判断脓毒症预后的临床价值[J].解放军医学杂志,2020,45(7):746-750.
[22] 陈萍,侯仕荣.急性缺血性脑卒中患者血清血栓调节蛋白、凝血酶激活纤溶抑制物及相关炎性因子水平的变化及其临床意义[J].实用医院临床杂志,2020,17(3):30-32.
[23] 曾庆波,张念清,余婷,等.血栓调节蛋白对脓毒症性凝血病的诊断价值[J].解放军医学杂志,2021,46(6):593- 597.
[24] 吴玉.血栓相关指标检测对急性心肌梗死患者发生主要不良心血管事件的预测价值[J].中国当代医药,2023, 30(2):163-166,170.
[25] 柯向群,马金鹏,保成英.基于FMEA的精细化护理模式联合早期俯卧位通气在急性呼吸窘迫综合征患者中的应用及其对LBP、sTM和EVLWI的影响[J].中国急救复苏与灾害医学杂志,2022,17(4):512-516.
[26] 杨念龙,蔡晓,张琪,等.血栓标志物对慢性阻塞性肺疾病合并深静脉血栓的诊断价值[J].中国临床研究,2021, 34(11):1470-1473.
[27] Sano T,Terai Y,Daimon A,et al. Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency-The leading cause of preeclampsia [J]. Placenta,2018,65:1-6.
[28] Alpoim PN,Perucci LO,Godoi LC,et al. Oxidative stress markers and thrombomodulin plasma levels in women with early and late severe preeclampsia [J]. Clin Chim Acta,2018, 23(483):234-238. |
|
|
|